Clinical trials are registered on the鈥痵ite through a web-based data entry system called the鈥. Some terms used in relation to accounts in the PRS include:
Any 91探花faculty, staff or student who is eligible to use the 91探花IRB鈥 for review of their studies may use the 91探花account to register clinical trials in which the 91探花is engaged in the research, even for trials that were reviewed by a non- 91探花IRB instead of the 91探花IRB.
To create your user account, following the instructions outlined in the SOP Creating a CT.gov User Account. Requests for a new user account are usually completed within 2 business days once the Regulatory Affairs team receives the request.
To assist researchers, HSD has linked to CT.gov Quick Overview Guides from the PRS site.
General information on different PRS roles and responsibilities can be found in section 3.1 of the . The following provides UW-specific information:
Sponsor (or Sponsor Organization) – The 91探花is a Sponsor Organization; it is listed in the PRS system as鈥UWashington.
Administrator – HSD鈥檚 Regulatory Affairs team serves as the Administrator for the UWashington account.鈥疌ontact them through鈥hsdreprt@uw.edu.
Responsible Party – The 91探花PI should be identified as the Responsible Party for studies reviewed by HSD. For studies managed under the Fred Hutch/ 91探花Cancer Consortium, a PI who initiates or conducts an investigator-initiated clinical trial is designated as the Responsible Party, but the Responsible Party for other types of interventional trials is usually the Sponsor.
HSD reviews all incoming IRB applications and certain study modifications to determine whether the study is required to register and report results on CT.gov. The Regulatory Affairs staff at HSD will send an email to the study team if the trial meets these requirements and outline the steps for completing registration.
If the study is required to register in PRS, Regulatory Affairs staff will initiate the trial registration for the PI in PRS. The PI will need to complete the registration in PRS no later than 21 days after enrollment of the first study participant or within 1 year of IRB approval (HSD Policy), whichever occurs first. Registration is completed when a National Clinical Trial (NCT) number has been assigned to the study record.
Generally, each IRB application will have its own PRS study registration. However, contact HSD at鈥hsdreprt@uw.edu鈥痳egarding unique situations that may require more than one study registration for a study (e.g., NIH requests two separate registrations). Include 鈥CT.gov鈥欌痠n the subject line of your email to help triage your message efficiently.
After receiving the email from the Regulatory Affairs staff regarding initiation of trial registration, log into the to enter data and complete registration. Information is entered by the study team in the trial record by completing a series of topic-specific sections (called modules) in the 鈥楶rotocol Section鈥 located on the 鈥楻ecord Summary鈥 page.
The following documents and links provide guidance and instructions on how to enter data into the modules:
Additional resources from CT.gov:

Section 8 of the describes how to identify and resolve records with problems.
For specific questions related to data entry or registration issues for your specific trial, we recommend contacting register@clinicaltrials.gov for assistance.
For general questions, contact HSD at hsdreprt@uw.edu for assistance. Include 鈥颁罢.驳辞惫鈥 in the subject line of your email to help triage your message efficiently.
For assistance with studies managed by the Cancer Consortium鈥檚 Clinical Research Support (CRS) Office, contact CRS at CTgov@fredhutch.org. More information can also be found on the .